Flamel Technologies S.A. (ADR) (NASDAQ:FLML)

CAPS Rating: 5 out of 5

A biopharmaceutical company principally engaged in the development of two unique polymer-based drug delivery technologies for the improvement of medical applications.

Recs

0
Player Avatar scrubs620 (< 20) Submitted: 9/12/2007 8:01:25 PM : Outperform Start Price: $9.95 FLML Score: -49.59

New license with Wyeth for the use of its protein delivery system.

Featured Broker Partners


Advertisement